Literature DB >> 1853786

Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells.

P D Greenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1853786     DOI： 10.1016/s0065-2776(08)60778-6

Source DB:  PubMed          Journal:  Adv Immunol        ISSN： 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  128 in total

1.  Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood.

Authors:  W Herr; E Ranieri; A Gambotto; L S Kierstead; A A Amoscato; L Gesualdo; W J Storkus
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 2.  T cell receptor usage in malignant diseases.

Authors:  E Halapi; M Jeddi-Tehrani; A Osterborg; H Mellstedt
Journal:  Springer Semin Immunopathol       Date:  1999

3.  The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein.

Authors:  T Matsutake; P K Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 4.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

5.  Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.

Authors:  C Yee; J A Thompson; D Byrd; S R Riddell; P Roche; E Celis; P D Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

Review 6.  Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends.

Authors:  William Y Ho; Cassian Yee; Philip D Greenberg
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

7.  Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen.

Authors:  M C Gong; J B Latouche; A Krause; W D Heston; N H Bander; M Sadelain
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

8.  CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.

Authors:  M Boesen; I M Svane; A M Engel; J Rygaard; A R Thomsen; O Werdelin
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

9.  The laboratory opossum (Monodelphis domestica) as a natural mammalian model for human cancer research.

Authors:  Zhiqiang Wang; Gene B Hubbard; Fred J Clubb; John L Vandeberg
Journal:  Int J Clin Exp Pathol       Date:  2008-11-06

Review 10.  Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

Authors:  N P Restifo; Y Kawakami; F Marincola; P Shamamian; A Taggarse; F Esquivel; S A Rosenberg
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1993-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.